Listen
IKARAN
-
Opinions on drugs -
Posted on
May 23 2012
- Updated on
Jun 14 2012
Reason for request
- Re-assessment of Actual Benefit of proprietary medicinal products based on dihydroergotamine, in compliance with article R163-21 of the French Social Security Code and
-
Clinical Benefit
| Insufficient |
The actual benefit offered by this proprietary medicinal product in the preventative treatment of migraine is insufficient. |
Documents
Contact Us
Évaluation des médicaments
